Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes by benforred | Jan 21, 2026
Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects (LIPOKINES) by benforred | Jan 20, 2026
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy by benforred | Jan 19, 2026
Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan’s Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose) (HGPO-DUN) by benforred | Jan 19, 2026